| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
-Induced Interferon Regulatory Factor-1 (IRF-1) Expression in Rodent and Human Islet Cells Precedes Nitric Oxide Production1
Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden (M.F., D.L.E.) and Department of Metabolism and Endocrinology, Diabetes Research Center, Vrije Universiteit Brussel, Brussels, Belgium (D.L.E.)
Address all correspondence and requests for reprints to: Malin Flodström, Department of Medical Cell Biology, Uppsala University, Box 571, S-751 23 Uppsala, Sweden. E-mail: malin.flodstrom{at}medcellbiol.uu.se
The radical nitric oxide (NO) may be a mediator of ß-cell damage in
IDDM. The cytokines IFN-
and IL-1ß are required for expression of
the enzyme nitric oxide synthase (iNOS), and NO production by human
pancreatic islets. In this study, possible mechanisms by which IFN-
participates in iNOS messenger RNA (mRNA) expression were evaluated in
both rodent and human islets cells. Addition of IFN-
, before or
after arrest of IL-1ß-induced iNOS gene transcription by actinomycin
D, did not prolong iNOS mRNA half life in the rat insulin-producing
cell line RINm5F (RIN cells). IFN-
also failed to modify
IL-1ß-induced activation of the transcription factor
B (NF-
B)
in RIN cells, as determined by electrophoretic mobility shift assay.
However, IFN-
induced an early (30 min1 h) increase in interferon
regulatory factor-1 (IRF-1) mRNA expression and a later (2 h) 19-fold
increase in RIN cell nuclear IRF-1 protein content, an effect further
potentiated by IL-1ß. The total cellular content of IRF-1 protein
increased by 30- to 50-fold in human islets exposed for 28h to
IFN-
or IFN-
+ IL-1ß. IL-1ß alone induced a marginal and
transient increase in IRF-1. It has been previously reported that
nicotinamide prevents IL-1ß-induced IRF-1 expression in rat
pancreatic islets. However, nicotinamide (20 mM) presently
failed to prevent IL-1ß + IFN-
-induced IRF-1 protein expression in
human pancreatic islets. In conclusion, the effects of IFN-
on iNOS
expression can neither be explained by iNOS mRNA stabilization nor
increased NF-
B activation. However, IFN-
induces an early
increase in cellular IRF-1 content, and this may contribute to
increased iNOS mRNA expression.
This article has been cited by other articles:
![]() |
A. Goldberg, M. Parolini, B. Y. Chin, E. Czismadia, L. E. Otterbein, F. H. Bach, and H. Wang Toll-like receptor 4 suppression leads to islet allograft survival FASEB J, September 1, 2007; 21(11): 2840 - 2848. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gysemans, L. Ladriere, H. Callewaert, J. Rasschaert, D. Flamez, D. E. Levy, P. Matthys, D. L. Eizirik, and C. Mathieu Disruption of the {gamma}-Interferon Signaling Pathway at the Level of Signal Transducer and Activator of Transcription-1 Prevents Immune Destruction of {beta}-cells Diabetes, August 1, 2005; 54(8): 2396 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flodstrom-Tullberg, M. Hultcrantz, A. Stotland, A. Maday, D. Tsai, C. Fine, B. Williams, R. Silverman, and N. Sarvetnick RNase L and Double-Stranded RNA-Dependent Protein Kinase Exert Complementary Roles in Islet Cell Defense during Coxsackievirus Infection J. Immunol., February 1, 2005; 174(3): 1171 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Darville, S. Terryn, and D. L. Eizirik An Octamer Motif Is Required for Activation of the Inducible Nitric Oxide Synthase Promoter in Pancreatic {beta}-Cells Endocrinology, March 1, 2004; 145(3): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flodstrom-Tullberg, D. Yadav, R. Hagerkvist, D. Tsai, P. Secrest, A. Stotland, and N. Sarvetnick Target Cell Expression of Suppressor of Cytokine Signaling-1 Prevents Diabetes in the NOD Mouse Diabetes, November 1, 2003; 52(11): 2696 - 2700. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Stewart, Y. Choi, G. A. Johnson, L.-y. Yu-Lee, F. W. Bazer, and T. E. Spencer Roles of Stat1, Stat2, and Interferon Regulatory Factor-9 (IRF-9) in Interferon Tau Regulation of IRF-1 Biol Reprod, February 1, 2002; 66(2): 393 - 400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Blair, L. B. Maggi Jr., A. L. Scarim, and J. A. Corbett Role of Interferon Regulatory Factor-1 in Double-stranded RNA-induced iNOS Expression by Mouse Islets J. Biol. Chem., January 4, 2002; 277(1): 359 - 365. [Abstract] [Full Text] |
||||
![]() |
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, September 26, 2001; (2001) 211445998. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sekine, S. Fukumoto, T. Ishikawa, T. Okazaki, and T. Fujita GH Inhibits Interferon-{gamma}-Induced Signal Transducer and Activator of Transcription-1 Activation and Expression of the Inducible Isoform of Nitric Oxide Synthase in INS-1 Cells Endocrinology, September 1, 2001; 142(9): 3909 - 3916. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Darville and D. L. Eizirik Cytokine Induction of Fas Gene Expression in Insulin-Producing Cells Requires the Transcription Factors NF-{kappa}B and C/EBP Diabetes, August 1, 2001; 50(8): 1741 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liu, M. Darville, and D. L. Eizirik Double-Stranded Ribonucleic Acid (RNA) Induces {beta}-Cell Fas Messenger RNA Expression and Increases Cytokine-Induced {beta}-Cell Apoptosis Endocrinology, June 1, 2001; 142(6): 2593 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Karlsen, D. Pavlovic, K. Nielsen, J. Jensen, H. U. Andersen, F. Pociot, T. Mandrup-Poulsen, D. L. Eizirik, and J. Nerup Interferon-{gamma} Induces Interleukin-1 Converting Enzyme Expression in Pancreatic Islets by an Interferon Regulatory Factor-1-Dependent Mechanism J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 830 - 836. [Abstract] [Full Text] |
||||
![]() |
S. T. Azar, H. Tamim, H. N. Beyhum, M. Z. Habbal, and W. Y. Almawi Type I (Insulin-Dependent) Diabetes Is a Th1- and Th2-Mediated Autoimmune Disease Clin. Vaccine Immunol., May 1, 1999; 6(3): 306 - 310. [Full Text] [PDF] |
||||
![]() |
V. Faure, C. Hecquet, Y. Courtois, and O. Goureau Role of Interferon Regulatory Factor-1 and Mitogen-activated Protein Kinase Pathways in the Induction of Nitric Oxide Synthase-2 in Retinal Pigmented Epithelial Cells J. Biol. Chem., February 19, 1999; 274(8): 4794 - 4800. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Thompson, S. E. Porter, A. K. Bauer, K. C. Das, B. Ou, L. Dwyer-Nield, C. W. White, and A. M. Malkinson Cytokine-induced nitric oxide formation in normal but not in neoplastic murine lung epithelial cell lines Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L922 - L932. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Giannoukakis, W. A. Rudert, M. Trucco, and P. D. Robbins Protection of Human Islets from the Effects of Interleukin-1beta by Adenoviral Gene Transfer of an Ikappa B Repressor J. Biol. Chem., November 17, 2000; 275(47): 36509 - 36513. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cardozo, H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-kappa B-dependent Genes in Primary Rat Pancreatic beta -Cells J. Biol. Chem., December 21, 2001; 276(52): 48879 - 48886. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity PNAS, October 9, 2001; 98(21): 12191 - 12196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |